Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets ; volume:40 ; number:1 ; day:18 ; month:5 ; year:2021 ; pages:1-23 ; date:12.2021
Journal of experimental & clinical cancer research ; 40, Heft 1 (18.5.2021), 1-23, 12.2021
- Urheber
-
Luo, Xiang-Yuan
Wu, Kong-Ming
He, Xing-Xing
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-021-01968-w
- URN
-
urn:nbn:de:101:1-2021091719560335340364
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Luo, Xiang-Yuan
- Wu, Kong-Ming
- He, Xing-Xing
- SpringerLink (Online service)
Ähnliche Objekte (12)
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Inflammation as a therapeutic target for osteoarthritis: A literature review of clinical trials
Advances in management of hepatocellular cancer
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma
Recent Advances in Anti‐Atherosclerosis and Potential Therapeutic Targets for Nanomaterial‐Derived Drug Formulations
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Inflammation as a therapeutic target for osteoarthritis: A literature review of clinical trials
Advances in management of hepatocellular cancer
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma
Recent Advances in Anti‐Atherosclerosis and Potential Therapeutic Targets for Nanomaterial‐Derived Drug Formulations
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Inflammation as a therapeutic target for osteoarthritis: A literature review of clinical trials
Advances in management of hepatocellular cancer
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma